The firm is touting its AI-driven foundation model's ability to predict how any patient will respond to any drug, allowing sponsors to fine-tune their trials.

Under the revised operating plan and with the additional financing, cash and investments expected to provide runway into 2H 2028 (previously 2H 2027) and beyond anticipated primary endpoint readouts ...

The Company’s approach to drug development is based on more than 30 years of expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship.

Breaking Down the Clinical Trial Process Clinical trials are the backbone of modern oncology, often determining the most effective primary treatment for various types of cancer. They’re the ...

Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by ...

So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and ...

In this new role, Dr. Costa will work with the team of O’Neal clinical investigators to expand the number of potentially disease-altering clinical trials that we can offer our cancer patients, and to ...

Consider this: Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on the benefits of virtual randomized clinical trials ...

Clinical Trials Have a Research Site Demand and Supply Crisis. Here is How to Solve it As demand for trial sites increases, more investigators are overburdened or experiencing burnout.

Clinical trials are studies that test new medical interventions, such as a new type of drug, surgery, or medical device, on human volunteers. 1 They aim to determine whether the new treatment ...

Innovative Pulmonary Solutions Inc., a company developing a catheter-based device to treat chronic obstructive pulmonary disease, said it raised a $10.6 million Series B round in March to move its ...